Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07398287
PHASE2
Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
Sponsor: Region Skane
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).
Official title: Effect of L-menthol on Breathlessness and Exercise Capacity in Interstitial Lung Disease: a Randomized Crossover Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-02-15
Completion Date
2027-05
Last Updated
2026-02-09
Healthy Volunteers
No
Conditions
Interventions
DRUG
L-menthol
(Sigma-Aldrich, St. Louis, US)
OTHER
Placebo
Strawberry scent (Sigma-Aldrich, St. Louis, US)
Locations (2)
Blekinge Institute of Technology
Karlskrona, Blekinge County, Sweden
Lund University hospital and Region Skåne
Lund, Sweden